State pharmacy boards have authority that operates parallel to federal FDA action. 2025–2026 saw an increase in state board investigations of high-volume compounding operations.
Why state action matters
State pharmacy boards license pharmacies, inspect facilities, and can suspend or revoke licenses independent of federal FDA findings. A pharmacy in FDA-good-standing can still face state action.
2025–2026 wave
Florida, Texas, and California pharmacy boards opened formal investigations into high-volume compounding operations serving telehealth markets in 2025–2026. Some investigations have produced public consent orders; others remain ongoing.
How to verify your provider's pharmacy partners
State pharmacy board websites typically publish license-status information. For each state where a partner pharmacy operates, you can look up: license number, status (active, suspended, probation), past disciplinary actions, and inspection history.
Why disclosure depth matters
If your provider names pharmacy partners by name (e.g., NexLife's six named partners), you can verify each one's state-board standing. If your provider declines to name partners, you cannot.
What to look for
- Active license in good standing
- No active disciplinary actions
- Inspection history without serious deficiencies
- For 503B partners: FDA registration current and in good standing